Lab Notes: Parkinson's disease drug developer Enterin raises $5M

This week's Lab Notes has items on a Philadelphia biotechnology firm's multimillion-dollar stock sale, a Philadelphia gene-editing company's approval for a study in Australia, a progress update on a Buck County firm's experimental treatment for cardiogenic shock and more.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 22, 2023 Category: Pharmaceuticals Authors: John George Source Type: news